IP Verse

Buffer Solutions Having Selective Bactericidal Activity Against Gram Negative Bacteria And Methods Of Using Same - EP2711024

The patent EP2711024 was granted to United Therapeutics on Mar 6, 2019. The application was originally filed on Sep 5, 2008 under application number EP13188882A. The patent is currently recorded with a legal status of "Revoked".

EP2711024

UNITED THERAPEUTICS
Application Number
EP13188882A
Filing Date
Sep 5, 2008
Status
Revoked
Oct 29, 2021
Publication Date
Mar 6, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKDec 5, 2019ELKINGTON AND FIFEADMISSIBLE
TEVA PHARMACEUTICALSNov 22, 2019D YOUNGADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONEP0347243
OPPOSITIONEP0347243
OPPOSITIONWO2007092343
SEARCHUS5153222
SEARCHWO2005099680
SEARCHWO2007092343

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- "BACTERIA AND LIFE PROCESSES", SRIVASTAVA et al., Understanding Bacteria, 978-1-4020-1633-6, KLU邺R ACADEMIC PUBLISHERS, (20030000), pages 117 - 119, XP055660391
OPPOSITION- FDA, "REMODULIN (treprostinil sodium) Injection", FDA - PRODUCT INFORMATION, (20060320), pages 1 - 14, XP055660389
OPPOSITION- HAMMES, W. et al., "Mode of Action of Glycine on the Biosynthesis of Peptidoglycan", J Bacterial., (19731111), vol. 6, no. 2, pages 1029 - 1053, XP055039465
OPPOSITION- "THE EFFECT OF pH GROWTH AND ON BACTERIAL VIABILITY", HUGO, W.N. et al, An Introduction to Microbiology, WILLIAM HEINEMANN MEDICAL, (19720000), pages 57 - 59, XP055660392
OPPOSITION- "The pH", EUGENE L. PARROTT, Burgess Publishing. Fundamental Pharmaceutics, Burgess Publishing, (19700000), page 233, XP055660401
OPPOSITION- "The pH", PARROTT, E.L. et al., Experimental Pharmaceutical Technology. 2nd ed., Burgess Publishing, (19650000), page 140, XP055660399
OPPOSITION- KALLEN, A.J. et al., "Bloodstream Infections in Patients Given Treatment With Intravenous Prostanoids", Infect Control Hosp Epidemiol, (20080400), vol. 29, no. 4, pages 342 - 349, XP055660390
OPPOSITION- MINAMI, M. et al., "Effect of Glycine on Helicobacter pylori In Vitro", Antimicrob. Agents Chemother., (20040000), vol. 48, no. 10, doi:10.1128/AAC.48.10.3782-3788.2004, pages 3782 - 3788, XP055312962
SEARCH- TASK FORCE MEMBERS: NAZZARENO GALIE (CHAIRPERSON) (ITALY) ADAM TORBICKI (POLAND) ROBYN BARST (USA) PHILIPPE DARTEVELLE (FRANCE) SH, "Guidelines on diagnosis and treatment of pulmonary arterial hypertension - The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology", EUROPEAN HEART JOURNAL, OXFORD UNIVERSITY PRESS, GB, FR, (20041201), vol. 25, no. 24, doi:10.1016/J.EHJ.2004.09.014, ISSN 0195-668X, pages 2243 - 2278, XP004677669 [A] 1-26 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents